|
Orthologous residues
|
|
ER‑alpha (human): S167‑p, ER‑alpha (mouse): S171‑p, ER‑alpha (rat): S172‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, electrophoretic mobility shift, mutation of modification site
|
|
Relevant cell lines - cell types - tissues:
BHK-21 (fibroblast), COS (fibroblast), MCF-7 (breast cell)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
hamster, human, monkey
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
p90RSK (human)
|
activation of upstream enzyme, mutation in upstream enzyme recognition motif, co-immunoprecipitation
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
EGF
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (process):
transcription, altered
|